Contents
Issue 142 • May 2024
In association with
In Depth
Anticipation rises for RSV rollout as positive data emerges
Continuous monitoring expands aseptic knowledge and data in real time
Molecular glues are the latest craze in pharma research, but what are they?
Using pharmacovigilance to turn reactive investigation into active discovery
Lenmeldy becomes world’s most expensive drug
Q&A: BARDA wants to back tech that can combat multiple infections, says chief